LGALS3 and chronic obstructive pulmonary disease: One significant issue is that this meta-analysis focused on comparing the different serum levels of galectin-3 between cases and controls, and it did not determine the optimal cutoff value of galectin-3 for discriminating COPD and AECOPD from the patient population.